LivaNova

LivaNova is a leading global medical technology company headquartered in London. Established in 2015, LivaNova has quickly become a pioneer in the field of medical devices, focusing on delivering cutting-edge healthcare solutions. The company is committed to improving the quality of life for its patients through innovative products and services.

With a workforce of over 2,900 employees, LivaNova operates within two main business units: Cardiovascular and Neuromodulation. The Cardiovascular unit specialises in providing advanced technology for cardiac surgery and cardiopulmonary solutions, while the Neuromodulation unit focuses on developing therapies for treating neurological disorders. LivaNova's dedication to research and development ensures that they remain at the forefront of technological advancements in the healthcare sector.

Under the leadership of CEO Vladimir Makatsaria, LivaNova continues to expand its global reach, offering life-changing technologies to patients worldwide. The company's relentless pursuit of excellence in medical innovation has positioned them as a trusted partner in the healthcare industry, committed to transforming lives through their comprehensive range of products and services.